openPR Logo
Press release

Precision Medicine Market Outlook| Key Players are Pfizer, Novartis, QIAGEN, Quest Diagnostics, Teva Pharmaceuticals, Biocrates Life Sciences AG, Eagle Genomics Ltd.

10-24-2018 06:21 PM CET | Health & Medicine

Press release from: Precision Medicine

Precision Medicine Market

Precision Medicine Market

Drug discovery dominated the precision medicine market in 2016 followed by gene sequencing which is expected to show a considerable growth over the coming years. Availability of next generation sequencing based genetic tests for rapid sequencing and identification of large human genome along with favourable regulatory guidelines by U.S. FDA for validation of such genetic tests is a major advancement in precision medicine accelerating gene sequencing revenue growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/671

Companion diagnostics is poised to be the fastest growing segment with over 11.5% CAGR owing to its ability to provide essential information for the safety and effectiveness of a specific drug or therapeutic product for targeted patient groups.

Prominent Players are:
• Pfizer
• Novartis
• QIAGEN
• Quest Diagnostics
• Teva Pharmaceuticals
• Biocrates Life Sciences AG
• Eagle Genomics Ltd.
• NanoString Technologies, Inc.

CNS will show considerable growth over the coming years owing to the rising economic burden of central nervous system disorders which fosters the need to develop genomic platforms in combination with electronic health record data based on clinical phenotypes for effective targeted treatment of such diseases.

UK precision medicine market should witness robust growth over the forecast period. Favorable government initiatives and increasing funding on research activities such as the launch of stratified medicine initiative in 2011 with €60 million budget focused on biomarker, patient cohorts, genomic and phenotypic analysis will fuel regional growth. Further, the launch of 100,000 Genomes Project in 2012 by Genomics England with €250-300 million funding for genomics has paved the way for individualized treatment for cancer patients and escalate regional market size.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/671

Precision Medicine Market by Technology
o Big data analytics
o Bioinformatics
o Gene sequencing
o Drug discovery
o Companion diagnostics

Precision Medicine Market by Application
o Oncology
o Respiratory
o CNS
o Immunology

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Precision Medicine Market Outlook| Key Players are Pfizer, Novartis, QIAGEN, Quest Diagnostics, Teva Pharmaceuticals, Biocrates Life Sciences AG, Eagle Genomics Ltd. here

News-ID: 1326510 • Views:

More Releases from Precision Medicine

Global precision medicine Market Report 2019 Companies included Johnson & Johnson, IBM, GE Healthcare, Illumina, Roche and Others
Global precision medicine Market Report 2019 Companies included Johnson & Johnso …
#7th Edition precision medicine market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global precision medicine market report: sales@marketreportscompany.com The precision medicine market delivers a wide array of primary and secondary data with respect to regional and global market. In-depth
Novartis, Pfizer, NanoString Technologies, Inc. Profiled in Precision Medicine Market|Key Players: QIAGEN, Quest Diagnostics, Teva Pharmaceuticals, Biocrates Life Sciences AG
Novartis, Pfizer, NanoString Technologies, Inc. Profiled in Precision Medicine M …
The Precision Medicine Market to exceed USD 96 billion by 2024; according to a new research report by Global Market Insights. Rising prevalence of cancer across the globe fuels the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size. Advancement in cancer biology coupled with increased funding for cancer research will fuel industry expansion. For instance, in
Precision Medicine Market Report 2018 Companies included Thermo Fisher Scientific, Novartis, Abbott Laboratories, Almac Group, Intel Corporation, Biomrieux Sa, Cepheid, Qiagen, Randox Laboratories and Others
Precision Medicine Market Report 2018 Companies included Thermo Fisher Scientifi …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Precision Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2017
Precision Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends …
Researchmoz added Most up-to-date research on "Precision Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2017" to its huge collection of research reports. This report studies Precision Medicine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market,

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion